Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Al Ali, Haifa Kathrin ^a   Eisfeld, Ann Kathrin ^a   Westerman, Mark ^b   Krahl, Rainer ^a   Leiblein, Sabine ^a   Liebert, Uwe Gerd ^a   Hehme, Marianne ^c   Teupser, Daniel ^a   Niederwieser, Dietger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Intrinsic LifeSciences LLC   (United States)

^c NOVARTIS PHARMA GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEPCIDIN; IRON;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; GENOTYPE; HUMAN; IRON OVERLOAD; KIDNEY FUNCTION; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 79959277982     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/491058     Document Type: Article

References (38)

1. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., Vaulont S., Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice Proceedings of the National Academy of Sciences of the United States of America 2001 98 15 8780 8785 (Pubitemid 32678104)
2. Verga Falzacappa M. V., Muckenthaler M. U., Hepcidin: Iron-hormone and anti-microbial peptide Gene 2005 364 1-2 37 44 (Pubitemid 41773232)
3. Zhang A. S., Enns C. A., Molecular mechanisms of normal iron homeostasis Hematology / The Education Program of the American Society of Hematology 2009 207 214
4. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loral O., A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload Journal of Biological Chemistry 2001 276 11 7811 7819
5. Lin L., Valore E. V., Nemeth E., Goodnough J. B., Gabayan V., Ganz T., Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4 Blood 2007 110 6 2182 2189 (Pubitemid 47443938)
6. Nemeth E., Valore E. V., Territo M., Schiller G., Lichtenstein A., Ganz T., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 2003 101 7 2461 2463 (Pubitemid 36857598)
7. Ganz T., Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 2003 102 3 783 788 (Pubitemid 36917762)
8. Nemeth E., Ganz T., Hepcidin and iron-loading anemias Haematologica 2006 91 6 727 732 (Pubitemid 44014536)
9. Fix O. K., Kowdley K. V., Hereditary hemochromatosis Minerva Medica 2008 99 6 605 617
10. Hanson E. H., Imperatore G., Burke W., HFE gene and hereditary hemochromatosis: a HuGE review American Journal of Epidemiology 2001 154 3 193 206 (Pubitemid 32701154)
11. Pedersen P., Milman N., Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants Annals of Hematology 2009 88 8 775 784
12. Pantopoulos K., Function of the hemochromatosis protein HFE: lessons from animal models World Journal of Gastroenterology 2008 14 45 6893 6901
13. Majhail N. S., Lazarus H. M., Burns L. J., Iron overload in hematopoietic cell transplantation Bone Marrow Transplantation 2008 41 12 997 1003 (Pubitemid 352034174)
14. Majhail N. S., DeFor T., Lazarus H. M., Burns L. J., High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors Biology of Blood and Marrow Transplantation 2008 14 7 790 794 (Pubitemid 351773155)
15. World Medical Association, Declaration of Helsinki: ethical principles for medical research involving human subjects Journal of International Biotechnology Law 2004 15 124 129
16. Glucksberg H., Storb R., Fefer A., Clinical manifestations of graft versus host disease in human recipients of marrow from HL A matched sibling donors Transplantation 1974 18 4 295 304
17. Ganz T., Olbina G., Girelli D., Nemeth E., Westerman M., Immunoassay for human serum hepcidin Blood 2008 112 10 4292 4297
18. Lyon E., Mutation detection using fluorescent hybridization probes and melting curve analysis Expert Review of Molecular Diagnostics 2001 1 1 92 101 (Pubitemid 34654451)
19. Bennett J. M., Consensus statement on iron overload in myelodysplastic syndromes American Journal of Hematology 2008 83 11 858 861
20. Gattermann N., Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload Leukemia Research 2007 31 3 S10 S15
21. Piperno A., Classification and diagnosis of Iron overload Haematologica 1998 83 5 447 455 (Pubitemid 28299253)
22. Tanno T., Bhanu N. V., Oneal P. A., Goh S. H., Staker P., Lee Y. T., Moroney J. W., Reed C. H., Luban N. L. C., Wang R. H., Eling T. E., Childs R., Ganz T., Leitman S. F., Fucharoen S., Miller J. L., High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin Nature Medicine 2007 13 9 1096 1101 (Pubitemid 47517510)
23. Kemna E., Pickkers P., Nemeth E., Van Der Hoeven H., Swinkels D., Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS Blood 2005 106 5 1864 1866 (Pubitemid 41208606)
24. Muckenthaler M. U., Fine tuning of hepcidin expression by positive and negative regulators Cell Metabolism 2008 8 1 1 3 (Pubitemid 351859233)
25. Van Dijk B. A. C., Laarakkers C. M. M., Klaver S. M., Jacobs E. M. G., Van Tits L. J. H., Janssen M. C. H., Swinkels D. W., Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevated and normal ferritin levels British Journal of Haematology 2008 142 6 979 985
26. Piperno A., Girelli D., Nemeth E., Trombini P., Bozzini C., Poggiali E., Phung Y., Ganz T., Camaschella C., Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis Blood 2007 110 12 4096 4100 (Pubitemid 350248467)
27. Wallace D. F., Summerville L., Crampton E. M., Frazer D. M., Anderson G. J., Subramaniam V. N., Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload Hepatology 2009 50 6 1992 2000
28. Lee P., Peng H., Gelbart T., Beutler E., The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and -microglobulin-deficient hepatocytes Proceedings of the National Academy of Sciences of the United States of America 2004 101 25 9263 9265 (Pubitemid 38812863)
29. Roy C. N., Custodio. O., De Graaf J., Schneider S., Akpan I., Montross L. K., Sanchez M., Gaudino A., Hentze M. W., Andrews N. C., Muckenthaler M. U., An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice Nature Genetics 2004 36 5 481 485 (Pubitemid 38620032)
30. Frazer D. M., Wilkins S. J., Millard K. N., McKie A. T., Vulpe C. D., Anderson G. J., Increased hepcidin expression and hypoferraemia associated with an acute phase response are not affected by inactivation of HFE British Journal of Haematology 2004 126 3 434 436 (Pubitemid 39005725)
31. Pietrangelo A., Hemochromatosis 1998: is one gene enough? Journal of Hepatology 1998 29 3 502 509 (Pubitemid 28396673)
32. Waheed A., Parkkila S., Zhou X. Y., Tomatsu S., Tsuchihasi Z., Feder J. N., Schatzman R. C., Britton R. S., Bacon B. R., Sly W. S., Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with 2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells Proceedings of the National Academy of Sciences of the United States of America 1997 94 23 12384 12389
33. Veneri D., Franchini M., Krampera M., De Matteis G., Solero P., Pizzolo G., Analysis of HFE and TFR2 gene mutations in patients with acute leukemia Leukemia Research 2005 29 6 661 664 (Pubitemid 40603566)
34. Lim Z. Y., Fiaccadori V., Gandhi S., Hayden J., Kenyon M., Ireland R., Marsh J., Ho A. Y. L., Mufti G. J., Pagliuca A., Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation Leukemia Research 2010 34 6 723 727
35. Mahindra A., Bolwell B., Sobecks R., Rybicki L., Pohlman B., Dean R., Andresen S., Sweetenham J., Kalaycio M., Copelan E., Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation British Journal of Haematology 2009 146 3 310 316
36. Kataoka K., Nannya Y., Hangaishi A., Imai Y., Chiba S., Takahashi T., Kurokawa M., Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation 2009 15 2 195 204
37. Pullarkat V., Blanchard S., Tegtmeier B., Dagis A., Patane K., Ito J., Forman S. J., Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation Bone Marrow Transplantation 2008 42 12 799 805
38. Kanda J., Mizumoto C., Kawabata H., Ichinohe T., Tsuchida H., Tomosugi N., Matsuo K., Yamashita K., Kondo T., Ishikawa T., Uchiyama T., Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation 2009 15 8 956 962